AXSOME THERAPEUTICS, INC. Current Liabilities
AXSOME THERAPEUTICS, INC. (AXSM) had Current Liabilities of $460.45 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-10
- 2026-06-30: Liabilities, Current $460.45M.
- 2026-03-31: Liabilities, Current $439.21M.
- 2025-12-31: Liabilities, Current $378.84M.
- 2025-09-30: Liabilities, Current $360.29M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $460.45M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $439.21M 10-Q · filed 2026-05-04 | |
| 2025-12-31 | $378.84M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $360.29M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $342.10M 10-Q · filed 2025-08-04 | |
| 2025-03-31 | $243.91M 10-Q · filed 2025-05-05 | |
| 2024-12-31 | $230.10M 10-K · filed 2026-02-23 | |
| 2024-09-30 | $196.19M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $186.57M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $144.05M 10-Q · filed 2024-05-06 | |
| 2023-12-31 | $138.85M 10-K · filed 2025-02-18 | |
| 2023-09-30 | $114.66M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $114.97M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $100.65M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $96.56M 10-K · filed 2024-02-23 | $96.56M 10-K · filed 2023-02-28 |
| 2022-09-30 | $60.28M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $42.57M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $24.55M 10-Q · filed 2022-05-02 | |
| 2021-12-31 | $23.07M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $24.71M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $22.86M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $21.68M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $23.44M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $20.34M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $23.00M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $26.10M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $24.49M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $18.51M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $13.07M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $7.71M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $10.82M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $10.94M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $9.53M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $9.42M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $12.18M 10-K · filed 2019-03-15 | |
| 2017-09-30 | $8.40M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $8.21M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $8.36M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $7.17M 10-K · filed 2018-03-07 | |
| 2016-09-30 | $6.74M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $5.10M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $3.91M 10-Q/A · filed 2016-08-09 | |
| 2015-12-31 | $2.63M 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |